Recently, Smchd1 has been shown to act as a tumor suppressor [13] and mutations in SMCHD1 have been shown to be tightly associated with the human disease facioscapulohumeral dystrophy type 2 (FSHD2) [14]. This evidence concerns the gene SMCHD1 and facioscapulohumeral muscular dystrophy 2.